 | |
- close
- close
Business Wire
Jan 22
Comment
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home care and hospice companies, today announced that William F. Borne, Chief Executive Officer, and Dale E. Redman, Chief Financial Officer, will present at the Jefferies 2010 Global Healthcare
Market Intelligence Center
Jan 20
Comment
Amedisys (NASDAQ: AMED) hit a new 52-Week high of $61.75 so far today. AMED signed an agreement with Humana (HUM) this morning under which AMED will provide home health services to Humana's Medicare Advantage members. Currently the stock is up...
Business Wire
Jan 20
Comment
Amedisys Inc. (NASDAQ: AMED), one of America's leading home health nursing companies, today announced that it has signed a national agreement with Humana Inc. (NYSE: HUM) to provide home health services to Humana’s Medicare Advantage members
Business Wire
Jan 19
Comment
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home care and hospice companies, announced today that G. Patrick Thompson, Jr., formerly Executive Vice President and Chief Administrative Officer of The Shaw Group, has joined Amedisys as the
Business Wire
Jan 11
Comment
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home care and hospice companies, today announced that William F. Borne, Chief Executive Officer, and Dale E. Redman, Chief Financial Officer, will present at the 28th Annual J.P. Morgan
StreetInsider.com
Jan 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Amedisys+%28AMED%29+Appoints+Michael+Snow+to+COO+and+Tim+Barfield+to+CDO/5217890.html for the full story.
Business Wire
Jan 5
Comment
Amedisys, Inc. (NASDAQ: AMED) one of America’s leading home care and hospice companies, announced today that Michael D. Snow, formerly President and CEO of Wellmont Health System, will join Amedisys as the Company’s new Chief Operating Officer
Business Wire
Jan 4
Comment
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health nursing companies, today announced that it has received the regulatory approvals from the state of New Jersey and that it has completed the acquisition of the home health operations
Market Intelligence Center
Dec 21
Comment
Amedisys (NASDAQ: AMED) opened at $46.19. So far today, the stock has hit a low of $46.04 and a high of $46.88. AMED is now trading at $45.57, down $0.32 (-0.69%). Over the last 52 weeks the stock has ranged from a low of $25.20 to a high of...
Trade Radar
Dec 17
Comment
One of the features of this web site is what I refer to as the "super list" where I combine the results of two or more of the screens that the Alert HQ software performs and publish the resulting set of stocks.
Today I'd like to feature a stock...
Suggest other news sources for this topic
Thank you for your suggestion
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
AMED AT A GLANCE
References
| ||||||
|
|
